Location History:
- Stockton, CA (US) (2001)
- Law, GB (2002)
- Carluke, GB (2002)
Company Filing History:
Years Active: 2001-2002
Title: Ulrich Ixkes: Innovator in Neoplasia Treatment
Introduction
Ulrich Ixkes is a notable inventor based in Law, GB, recognized for his contributions to the field of medical treatments, particularly in the area of neoplasia. With a total of three patents to his name, Ixkes has made significant strides in developing methods to combat neoplastic cells.
Latest Patents
His latest patents include a method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-ones. This innovative approach focuses on inhibiting neoplastic cells and related conditions through the application of these specific compounds. Another significant patent is the method of inhibiting neoplastic cells with benzimidazole derivatives, which aims to address cancerous and precancerous lesions by exposing affected cells to these derivatives.
Career Highlights
Ixkes is currently associated with Cell Pathways, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, contributing to the understanding and treatment of neoplastic diseases.
Collaborations
He has collaborated with notable colleagues such as Gerhard J Sperl and Rifat Pamukcu, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Ulrich Ixkes stands out as an influential inventor in the medical field, particularly in the treatment of neoplasia. His innovative patents and collaborative efforts reflect his commitment to advancing cancer treatment methodologies.